phosphorus has been researched along with pamidronate in 14 studies
| Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (pamidronate) | Trials (pamidronate) | Recent Studies (post-2010) (pamidronate) |
|---|---|---|---|---|---|
| 48,074 | 1,126 | 17,139 | 2,220 | 368 | 444 |
| Protein | Taxonomy | phosphorus (IC50) | pamidronate (IC50) |
|---|---|---|---|
| Farnesyl pyrophosphate synthase | Homo sapiens (human) | 1.0745 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 6 (42.86) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bijvoet, OL; Body, JJ; Borkowski, A; Cleeren, A | 1 |
| Bijvoet, OL; Delwaide, P; Franchimont, P; Heynen, G | 1 |
| Dluhy, RG; Solomon, CG | 1 |
| Azuma, Y; Kiyoki, M; Ohta, T; Okabe, K; Oue, Y; Sato, H; Tsuchimoto, M | 1 |
| Ammann, P; Bonjour, JP; Budayr, AA; Burckhardt, P; Gertz, B; Jaquet-Müller, F; Jenzer, A; Rizzoli, R; Thiébaud, D; Zysset, E | 1 |
| Angeli, A; Berruti, A; Dogliotti, L; Fasolis, G; Fontana, D; Sperone, P; Torta, M | 1 |
| Golomb, G; Kimyagarov, A; Ornoy, A; Patlas, N; Yaffe, P | 1 |
| Adachi, K; Doi, K; Nakayama, H; Sugimoto, T; Suzuki, M | 1 |
| Braselton, WE; Fitzgerald, SD; Frese, KK; Kaneene, JB; Kruger, JM; Nachreiner, R; Rumbeiha, WK | 1 |
| Cincotta, M; Crisafulli, G; Frisina, N; Gaudio, A; Lasco, A; Morabito, N; Pizzoleo, MA; Tallarida, F; Trifiletti, A; Vergara, C | 1 |
| Akiba, T; Tanabe, K; Tokumoto, T; Toma, H | 1 |
| Glorieux, FH; Land, C; Rauch, F; Travers, R | 1 |
| Cunha, FQ; de Paula, FJA; Dick-de-Paula, I; Fukada, SY; Jordão, AA; Jorgetti, V; Nogueira-Barbosa, MH; Ramalho, LNZ; Spirlandeli, AL; Volpon, JB; Zamarioli, A | 1 |
| Filella, X; Florez, H; Guañabens, N; Mandelikova, S; Monegal, A; Peris, P | 1 |
1 review(s) available for phosphorus and pamidronate
| Article | Year |
|---|---|
[Treatment of bone disease in chronic kidney disease and in renal transplant recipients under K/DOQI clinical practice guidelines].
Topics: Bone Density; Bone Diseases, Metabolic; Calcitonin; Chronic Disease; Diphosphonates; Epoxy Compounds; Furosemide; Humans; Hyperparathyroidism, Secondary; Ion Exchange Resins; Kidney Diseases; Kidney Transplantation; Pamidronate; Parathyroidectomy; Phosphorus; Phosphorus, Dietary; Polyamines; Polyethylenes; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Testosterone; United States; Vitamin D; Vitamin D Deficiency | 2004 |
2 trial(s) available for phosphorus and pamidronate
| Article | Year |
|---|---|
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis.
Topics: Alkaline Phosphatase; Bone Density; Bone Resorption; Calcium; Diphosphonates; Drug Therapy, Combination; Female; Humans; Hydroxycholecalciferols; Infusions, Intravenous; Insulin-Like Growth Factor I; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Pamidronate; Parathyroid Hormone; Phosphorus; Prospective Studies; Sodium Fluoride; Time Factors; Treatment Outcome | 2003 |
Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
Topics: Adolescent; Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Calcium; Child; Child, Preschool; Diphosphonates; Female; Fractures, Bone; Humans; Infant; Infusions, Intravenous; Lumbar Vertebrae; Male; Osteogenesis Imperfecta; Pamidronate; Parathyroid Hormone; Phosphorus; Vitamin D | 2007 |
11 other study(ies) available for phosphorus and pamidronate
| Article | Year |
|---|---|
Treatment of malignancy-associated hypercalcemia with intravenous aminohydroxypropylidene diphosphonate.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Calcium; Cyclic AMP; Diphosphonates; Female; Head and Neck Neoplasms; Humans; Hydroxyproline; Hypercalcemia; Lung Neoplasms; Male; Middle Aged; Osteolysis; Pamidronate; Phosphorus | 1986 |
Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone.
Topics: Alkaline Phosphatase; Calcium; Diphosphonates; Fever; Humans; Hydroxyproline; Osteitis Deformans; Pamidronate; Phosphorus | 1982 |
Paraneoplastic endocrine syndromes.
Topics: Acromegaly; Adrenocorticotropic Hormone; Aminoglutethimide; Bromocriptine; Calcitonin; Cushing Syndrome; Diazoxide; Diphosphonates; Estrogens; Fluid Therapy; Hemangiopericytoma; Humans; Hypercalcemia; Hyperthyroidism; Hypoglycemia; Inappropriate ADH Syndrome; Ketoconazole; Mifepristone; Mineralocorticoids; Mitotane; Octreotide; Osteomalacia; Pamidronate; Paraneoplastic Endocrine Syndromes; Phosphorus; Plicamycin; Propylthiouracil; Saline Solution, Hypertonic; Somatostatin; Thyroid Neoplasms | 1994 |
Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models.
Topics: Alendronate; Animals; Autoradiography; Bone and Bones; Bone Resorption; Calcium; Carbon Radioisotopes; Diphosphonates; Disease Models, Animal; Dose-Response Relationship, Drug; Etidronic Acid; Hydroxycholecalciferols; Hypercalcemia; Male; Organ Culture Techniques; Osteoclasts; Pamidronate; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Tibia; Tissue Distribution | 1995 |
Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
Topics: Alendronate; Calcitriol; Calcium; Creatinine; Diphosphonates; Female; Humans; Hypercalcemia; Male; Neoplasms; Pamidronate; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Phosphorus; Proteins | 1994 |
Pamidronate administration improves the secondary hyperparathyroidism due to "Bone Hunger Syndrome" in a patient with osteoblastic metastases from prostate cancer.
Topics: Aged; Alkaline Phosphatase; Bone and Bones; Bone Neoplasms; Calcium; Collagen; Diphosphonates; Humans; Hyperparathyroidism, Secondary; Male; Metabolic Diseases; Osteoblastoma; Pain Measurement; Pamidronate; Parathyroid Hormone; Phosphorus; Prostate-Specific Antigen; Prostatic Neoplasms; Syndrome | 1997 |
Effects of continuous or cyclic administration of pamidronate on the skeleton in intact and oophorectomized young rats.
Topics: Animals; Antineoplastic Agents; Calcium; Diphosphonates; Female; Injections, Subcutaneous; Magnesium; Organ Size; Ovariectomy; Pamidronate; Phosphorus; Rats; Rats, Wistar; Tibia | 1997 |
The development of bone changes induced in rats by recombinant human granulocyte colony-stimulating factor is suppressed by bisphosphonate.
Topics: Animals; Body Weight; Bone Marrow; Bone Resorption; Calcium; Diphosphonates; Femur; Granulocyte Colony-Stimulating Factor; Humans; Leukocyte Count; Male; Organ Size; Osteogenesis; Pamidronate; Phosphorus; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Spleen; Tibia | 1999 |
Use of pamidronate disodium to reduce cholecalciferol-induced toxicosis in dogs.
Topics: Animals; Anti-Inflammatory Agents; Calcium; Cholecalciferol; Creatinine; Diphosphonates; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Kidney Cortex; Male; Pamidronate; Phosphorus; Potassium; Random Allocation; Sodium; Specific Gravity; Urea; Urine | 2000 |
Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment.
Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Remodeling; Bone Resorption; Carbon Tetrachloride; Core Binding Factor Alpha 1 Subunit; Diphosphonates; Disease Models, Animal; Liver Cirrhosis; Liver Diseases; Male; Mice, Inbred C57BL; Osteoprotegerin; Pamidronate; Phosphorus; RANK Ligand; Tartrate-Resistant Acid Phosphatase; X-Ray Microtomography | 2017 |
Clinical significance of increased serum levels of FGF-23 in fibrous dysplasia.
Topics: Adult; Aged; Alendronate; Biomarkers; Bone Density Conservation Agents; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibrous Dysplasia of Bone; Humans; Male; Middle Aged; Osteomalacia; Pamidronate; Phosphorus; Reference Values; Young Adult; Zoledronic Acid | 2018 |